TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives $10.75 Average Price Target from Analysts
Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Get Free Report) have been given an average rating of “Buy” by the eight brokerages that are covering the company, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month price […]
Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Get Free Report) have been given an average rating of “Buy” by the eight brokerages that are covering the company, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month price […]
